Introduce Fostamatinib in Low GI, Via Opening, New Tech 7

This code describes the administration of fostamatinib directly into the lower gastrointestinal tract. This is achieved through an existing body opening, such as the anus, or via a surgically created opening, like a colostomy. Fostamatinib is a novel medication, and its delivery via this route is considered a new technology procedure.

This code is used when fostamatinib is introduced into the colon, rectum, or anus for therapeutic purposes. This typically occurs in the context of clinical trials or specialized treatment protocols for conditions like chronic immune thrombocytopenia (ITP) where oral administration is not feasible or desired, and the lower GI tract is the target for absorption.

• Ensure documentation clearly specifies "fostamatinib" as the substance introduced.
• Verify the route of administration is explicitly "Lower GI" and "Via Natural or Artificial Opening."
• Confirm the procedure is documented as a "New Technology" procedure, as this is a key component of the code.